SEC Comment Letter for COLLEGIUM PHARMACEUTICAL, INC (COLL) (CIK 0001267565) (COLL) — Mar 23, 2020
COLLEGIUM PHARMACEUTICAL, INC (COLL) (CIK 0001267565)
Date: March 23, 2020 · CIK: 0001267565 · Accession: 0000000000-20-002523
AI Filing Summary & Sentiment
File numbers found in text: 333-237200
Letter
March 23, 2020 Joseph Ciaffoni President and Chief Executive Officer Collegium Pharmaceutical, Inc. 100 Technology Center Drive, Suite 300 Stoughton, MA 02072 Re:Collegium Pharmaceutical, Inc. Registration Statement on Form S-3 Filed March 16, 2020 File No. 333-237200 Dear Mr. Ciaffoni: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer L. Porter, Esq.
Show Raw Text
March 23, 2020
Joseph Ciaffoni
President and Chief Executive Officer
Collegium Pharmaceutical, Inc.
100 Technology Center Drive, Suite 300
Stoughton, MA 02072
Re:Collegium Pharmaceutical, Inc.
Registration Statement on Form S-3
Filed March 16, 2020
File No. 333-237200
Dear Mr. Ciaffoni:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jennifer L. Porter, Esq.